Table 1.

Expression of neomycin phosphotransferase and β-gal in peripheral blood and bone marrow of in utero–transduced sheep at 40 months posttransduction

Method of detectionSheep 690Sheep 691Sheep 692Sheep 694Sheep 697Sheep 698Sheep 703Sheep 704Sheep 705
PBBMPBBMPBBMPBBMPBBMPBBMPBBMPBBMPBBM
FDG FACS* 5.1 3.2 2.3 2.6 0.4 1.7 0.4 3.9 2.5 2.5 2.7 2.5 1.9 1.3 1.2 1.2 5.3 
β-gal FACS 5.4 6.5 3.3 3.0 4.6 2.2 0.8 4.7 1.9 5.6 2.7 6.4 6.4 2.1 4.9 3.8 6.4 6.5 
NPT FACS 2.9 3.0 1.4 1.5 3.0 1.2 5.8 3.7 5.8 2.5 3.8 2.6 4.1 2.7 3.3 2.4 4.3 
Method of detectionSheep 690Sheep 691Sheep 692Sheep 694Sheep 697Sheep 698Sheep 703Sheep 704Sheep 705
PBBMPBBMPBBMPBBMPBBMPBBMPBBMPBBMPBBM
FDG FACS* 5.1 3.2 2.3 2.6 0.4 1.7 0.4 3.9 2.5 2.5 2.7 2.5 1.9 1.3 1.2 1.2 5.3 
β-gal FACS 5.4 6.5 3.3 3.0 4.6 2.2 0.8 4.7 1.9 5.6 2.7 6.4 6.4 2.1 4.9 3.8 6.4 6.5 
NPT FACS 2.9 3.0 1.4 1.5 3.0 1.2 5.8 3.7 5.8 2.5 3.8 2.6 4.1 2.7 3.3 2.4 4.3 
*

Detection of β-gal activity by fluorescence-activated cell sorter (FACS) analysis using fluorescein di-β-D-galactopyranoside (FDG) as substrate from in utero–transduced sheep. Values represent the percentage of positive cells per 50 000 viable white cells after subtracting the values obtained with a control sheep.

Data obtained from FACS analysis of peripheral blood (PB) and bone marrow (BM) white cells from in utero–transduced sheep using antibodies to β-gal and neomycin phosphotransferase (NPT). Values represent the percentage of positive cells per 20 000 white cells after subtracting the minimal (< 0.2%) values obtained with a control sheep using the same gates. Expression of β-gal and NPT was also confirmed by performing immunofluorescence microscopy, and similar values were obtained, with no significant staining seen in any of the control sheep tested (data not shown). For FACS histograms representative of the staining obtained with these antibodies, see references 19, 20, and 54.

or Create an Account

Close Modal
Close Modal